Varicose veins

Varicose veins
Left leg of a male affected by varicose veins
Pronunciation
SpecialtyVascular surgery, dermatology
SymptomsNone, fullness, pain in the area
ComplicationsBleeding, superficial thrombophlebitis
Risk factorsObesity, not enough exercise, leg trauma, family history, pregnancy
Diagnostic methodBased on examination
Differential diagnosisArterial insufficiency, peripheral neuritis
TreatmentCompression stockings, exercise, sclerotherapy, surgery, endovenous ablation
PrognosisCommonly reoccur
FrequencyVery common

Varicose veins are a medical condition in which superficial veins become enlarged and twisted. Although usually just a cosmetic ailment, in some cases they cause fatigue, pain, itching, and nighttime leg cramps. These veins typically develop in the legs, just under the skin. Their complications can include bleeding, skin ulcers, and superficial thrombophlebitis. Varices in the scrotum are known as varicocele, while those around the anus are known as hemorrhoids. The physical, social, and psychological effects of varicose veins can lower their bearers' quality of life.

Varicose veins have no specific cause. Risk factors include obesity, lack of exercise, leg trauma, and family history of the condition. They also develop more commonly during pregnancy. Occasionally, they result from chronic venous insufficiency. Underlying causes include weak or damaged valves in the veins. They are typically diagnosed by examination, including observation by ultrasound.

By contrast, spider veins affect the capillaries and are smaller.

Treatment may involve lifestyle changes or medical procedures with the goal of improving symptoms and appearance. Lifestyle changes may include wearing compression stockings, exercising, elevating the legs, and weight loss. Possible medical procedures include sclerotherapy, laser surgery, and vein stripping. However, recurrence is common following treatment.

Varicose veins are very common, affecting about 30% of people at some point in their lives. They become more common with age. Women develop varicose veins about twice as often as men. Varicose veins have been described throughout history and have been treated with surgery since at least the second century BC, when Plutarch tells of such treatment performed on the Roman leader Gaius Marius.

Signs and symptoms

People with varicose veins might have a positive D-dimer blood test result due to chronic low-level thrombosis within dilated veins (varices).

Complications

Most varicose veins are reasonably benign, but severe varicosities can lead to major complications, due to the poor circulation through the affected limb.

Causes

How a varicose vein forms in a leg. Figure A shows a normal vein with a working valve and normal blood flow. Figure B shows a varicose vein with a deformed valve, abnormal blood flow, and thin, stretched walls. The middle image shows where varicose veins might appear in a leg.
Comparison of healthy and varicose veins

Varicose veins are more common in women than in men and are linked with heredity. Other related factors are pregnancy, obesity, menopause, aging, prolonged standing, leg injury and abdominal straining. Varicose veins are unlikely to be caused by crossing the legs or ankles. Less commonly, but not exceptionally, varicose veins can be due to other causes, such as post-phlebitic obstruction or incontinence, venous and arteriovenous malformations.

Venous reflux is a significant cause. Research has also shown the importance of pelvic vein reflux (PVR) in the development of varicose veins. Varicose veins in the legs could be due to ovarian vein reflux. Both ovarian and internal iliac vein reflux causes leg varicose veins. This condition affects 14% of women with varicose veins or 20% of women who have had vaginal delivery and have leg varicose veins. In addition, evidence suggests that failing to look for and treat pelvic vein reflux can be a cause of recurrent varicose veins.

There is increasing evidence for the role of incompetent perforator veins (or "perforators") in the formation of varicose veins and recurrent varicose veins.

Varicose veins could also be caused by hyperhomocysteinemia in the body, which can degrade and inhibit the formation of the three main structural components of the artery: collagen, elastin and the proteoglycans. Homocysteine permanently degrades cysteine disulfide bridges and lysine amino acid residues in proteins, gradually affecting function and structure. Simply put, homocysteine is a 'corrosive' of long-living proteins, i.e. collagen or elastin, or lifelong proteins, i.e. fibrillin. These long-term effects are difficult to establish in clinical trials focusing on groups with existing artery decline. Klippel–Trenaunay syndrome and Parkes Weber syndrome are relevant for differential diagnosis.[citation needed]

Another cause is chronic alcohol consumption due to the vasodilatation side effect in relation to gravity and blood viscosity.

Diagnosis

Clinical test

Clinical tests that may be used include:[citation needed]

Investigations

Traditionally, varicose veins were investigated using imaging techniques only if there was a suspicion of deep venous insufficiency, if they were recurrent, or if they involved the saphenopopliteal junction. This practice is now less widely accepted. People with varicose veins should now be investigated using lower limbs venous ultrasonography. The results from a randomised controlled trial on patients with and without routine ultrasound have shown a significant difference in recurrence rate and reoperation rate at 2 and 7 years of follow-up.

Stages

The CEAP (Clinical, Etiological, Anatomical, and Pathophysiological) Classification, developed in 1994 by an international ad hoc committee of the American Venous Forum, outlines these stages

Each clinical class is further characterized by a subscript depending upon whether the patient is symptomatic (S) or asymptomatic (A), e.g. C2S.

Treatment

Treatment can be either active or conservative.

Active

Treatment options include surgery, laser and radiofrequency ablation, and ultrasound-guided foam sclerotherapy. Newer treatments include cyanoacrylate glue, mechanochemical ablation, and endovenous steam ablation. No real difference could be found between the treatments, except that radiofrequency ablation could have a better long-term benefit.

Conservative

The National Institute for Health and Clinical Excellence (NICE) produced clinical guidelines in July 2013 recommending that all people with symptomatic varicose veins (C2S) and worse should be referred to a vascular service for treatment. Conservative treatments such as support stockings should not be used unless treatment was not possible.

The symptoms of varicose veins can be controlled to an extent with the following:

Procedures

Stripping

Stripping consists of removal of all or part the saphenous vein (great/long or lesser/short) main trunk. The complications include deep vein thrombosis (5.3%), pulmonary embolism (0.06%), and wound complications including infection (2.2%). There is evidence for the great saphenous vein regrowing after stripping. For traditional surgery, reported recurrence rates, which have been tracked for 10 years, range from 5% to 60%. In addition, since stripping removes the saphenous main trunks, they are no longer available for use as venous bypass grafts in the future (coronary or leg artery vital disease).

Other

Other surgical treatments are:

  • CHIVA method (ambulatory conservative haemodynamic correction of venous insufficiency) is a relatively low-invasive surgical technique that incorporates venous hemodynamics and preserves the superficial venous system. The overall effectiveness compared to stripping, radiofrequency ablation treatment, or endovenous laser therapy is not clear and there is no strong evidence to suggest that CHIVA is superior to stripping, radiofrequency ablation, or endovenous laser therapy for recurrence of varicose veins. There is some low-certainty evidence that CHIVA may result in more bruising compared to radiofrequency ablation treatment.
  • Vein ligation is done at the saphenofemoral junction after ligating the tributaries at the saphenofemoral junction without stripping the long saphenous vein, provided the perforator veins are competent and DVT is absent in the deep veins. With this method, the long saphenous vein is preserved.
  • Cryosurgery – A cryoprobe is passed down the long saphenous vein following saphenofemoral ligation. The probe is then cooled with NO2 or CO2 to −85 °F. The vein freezes to the probe and can be retrogradely stripped after 5 seconds of freezing. It is a variant of stripping. The only purpose of this technique is to avoid a distal incision to remove the stripper.

Sclerotherapy

A commonly performed non-surgical treatment for varicose and "spider leg veins" is sclerotherapy, in which medicine called a sclerosant is injected into the veins to make them shrink. The medicines that are commonly used as sclerosants are polidocanol (POL branded Asclera in the United States, Aethoxysklerol in Australia), sodium tetradecyl sulphate (STS), Sclerodex (Canada), hypertonic saline, glycerin and chromated glycerin. STS (branded Fibrovein in Australia) liquids can be mixed at varying concentrations of sclerosant and varying sclerosant/gas proportions, with air or CO2 or O2 to create foams. Foams may allow more veins to be treated per session with comparable efficacy. Their use in contrast to liquid sclerosant is still somewhat controversial[medical citation needed], and there is no clear evidence that foams are superior. Sclerotherapy has been used in the treatment of varicose veins for over 150 years. Sclerotherapy is often used for telangiectasias (spider veins) and varicose veins that persist or recur after vein stripping. Sclerotherapy can also be performed using foamed sclerosants under ultrasound guidance to treat larger varicose veins, including the great saphenous and small saphenous veins.

There is some evidence that sclerotherapy is a safe and possibly effective treatment option for improving the cosmetic appearance, reducing residual varicose veins, improving the quality of life, and reducing symptoms that may be present due to the varicose veins. There is also weak evidence that this treatment option may have a slightly higher risk of deep vein thrombosis. It is not known if sclerotherapy decreases the chance of varicose veins returning (recurrent varicose veins). It is also not known which type of substance (liquid or foam) used for the sclerotherapy procedure is more effective and comes with the lowest risk of complications.

Complications of sclerotherapy are rare, but can include blood clots and ulceration. Anaphylactic reactions are "extraordinarily rare but can be life-threatening," and doctors should have resuscitation equipment ready. There has been one reported case of stroke after ultrasound-guided sclerotherapy when an unusually large dose of sclerosant foam was injected.

Endovenous thermal ablation

Endovenous thermal ablation (EVTA) is a minimally invasive procedure used to treat varicose veins by delivering controlled heat inside the affected vein. The thermal energy damages the vein wall, causing it to shrink and triggering natural remodeling processes that lead to permanent closure of the vein. Unlike surgical stripping, the vein is not removed but remains in place and is gradually resorbed by the body over time. The procedure is usually performed under local tumescent anesthesia and is associated with less postoperative pain, fewer hematomas and nerve injuries, and generally faster recovery compared with open surgery. There are three main types of endovenous thermal ablation: laser (EVLA), radiofrequency (RFA), and steam ablation.

Early assessments, such as the Australian Medical Services Advisory Committee (MSAC) report in 2008, suggested that endovenous laser ablation (EVLA) was at least as effective overall as vein stripping and associated with fewer short-term complications, including deep vein thrombosis, nerve injury, postoperative infections, and hematomas. More recent systematic reviews and long-term studies confirm that EVLA and RFA have comparable long-term effectiveness to surgery, with differences mainly in recovery and early postoperative morbidity. In particular, EVLA and RFA are generally associated with shorter recovery times, earlier return to normal activities, and reduced early postoperative pain compared with surgical ligation and stripping. EVTA is considered by several international professional societies, including the Society for Vascular Surgery (SVS) and the European Society for Vascular Surgery (ESVS), as a first-line, less invasive alternative to traditional high ligation and vein stripping.

Steam ablation involves injecting pulses of steam into the affected vein, using water as the thermal agent. Clinical outcomes appear similar to those of EVLA or RFA, including vein closure rates and cosmetic results. However, steam treatment is currently rarely performed in routine clinical practice, because it is a newer technique with limited, smaller-scale studies compared with the well-established long-term data available for EVLA and RFA. Potential advantages include minimally invasive access, reduced postoperative pain, and rapid return to normal activities, but evidence remains limited compared with more established methods.

ELA and ERA require specialized training for doctors and special equipment. EVTA is performed as an outpatient procedure and does not require an operating theatre, nor does the patient need a general anaesthetic. Doctors use high-frequency ultrasound during the procedure to visualize the anatomical relationships between the saphenous structures.

Some practitioners also perform phlebectomy or ultrasound-guided sclerotherapy at the time of endovenous treatment. This is also known as an ambulatory phlebectomy. The distal veins are removed following the complete ablation of the proximal vein. This treatment is most commonly used for varicose veins off of the great saphenous vein, small saphenous vein, and pudendal veins. Follow-up treatment to smaller branch varicose veins is often needed in the weeks or months after the initial procedure.

Medical adhesive

Also called medical super glue, medical adhesive is an advanced non-surgical treatment for varicose veins during which a solution is injected into the diseased vein through a small catheter and under the assistance of ultrasound-guided imagery. The "super glue" solution is made of cyanoacrylate, aiming at sealing the vein and rerouting the blood flow to other healthy veins.

Post-treatment, the body will naturally absorb the treated vein which will disappear. Involving only a small incision and no hospital stay, medical super glue has generated great interest within the last years, with a success rate of about 96.8%.

A follow-up consultation is required after this treatment, just like any other one, in order to re-assess the diseased vein and further treat it if needed.[citation needed]

Echotherapy Treatment

In the field of varicose veins, the latest medical innovation is high-intensity focused ultrasound therapy (HIFU). This method is completely non-invasive and is not necessarily performed in an operating room, unlike existing techniques. This is because the procedure involves treating from outside the body, able to penetrate the skin without damage, to treat the veins in a targeted area. This leaves no scars and allows the patient to return to their daily life immediately.

Epidemiology

Varicose veins are most common after age 50. It is more prevalent in females. There is a hereditary role. It has been seen in smokers, those who have chronic constipation, and in people with occupations which necessitate long periods of standing such as wait staff, nurses, conductors (musical and bus), stage actors, umpires (cricket, javelin, etc.), the King's guards, lectern orators, security guards, traffic police officers, vendors, surgeons, etc.

References

  1. 1 2 3 4 5 6 7 8 9 10 "Varicose Veins". National Heart, Lung, and Blood Institute (NHLBI). Retrieved 20 January 2019.
  2. 1 2 3 4 5 6 7 8 9 10 11 12 "Varicose Veins – Cardiovascular Disorders". Merck Manuals Professional Edition. Retrieved 20 January 2019.
  3. 1 2 3 4 5 6 7 8 "Varicose Veins". medlineplus.gov. Retrieved 20 January 2019.
  4. ↑ Buttaro TM, Trybulski JA, Polgar-Bailey P, Sandberg-Cook J (2016). BOPOD – Primary Care: A Collaborative Practice. Elsevier Health Sciences. p. 609. ISBN 978-0-323-35521-6.
  5. ↑ "Varicose veins". Mayo Clinic. Retrieved 19 June 2024.
  6. ↑ Lumley E, Phillips P, Aber A, Buckley-Woods H, Jones GL, Michaels JA (April 2019). "Experiences of living with varicose veins: A systematic review of qualitative research" (PDF). Journal of Clinical Nursing. 28 (7–8): 1085–1099. doi:10.1111/jocn.14720. PMID 30461103.
  7. 1 2 "Varicose veins and spider veins". womenshealth.gov. 15 December 2016. Retrieved 21 January 2019.
  8. 1 2 Baram A, Rashid DF, Saqat BH (August 2022). "Non-randomized comparative study of three methods for great saphenous vein ablation associated with mini-phlebectomy; 48 months clinical and sonographic outcome". Annals of Medicine and Surgery. 80 104036. doi:10.1016/j.amsu.2022.104036. PMC 9283499. PMID 35846854.
  9. ↑ "Varicose veins Introduction – Health encyclopaedia". NHS Direct. 8 November 2007. Archived from the original on 9 November 2007. Retrieved 20 January 2019.
  10. ↑ Plutarchus (2007), Plutarch's Lives. 9: Demetrius and Antony. Pyrrhus and Caius Marius, The Loeb classical library ([Repr. der Ausg.] 1920 ed.), Cambridge, Mass.: Harvard Univ. Press, ISBN 978-0-674-99112-5
  11. 1 2 Tisi PV (January 2011). "Varicose veins". BMJ Clinical Evidence. 2011. PMC 3217733. PMID 21477400.
  12. 1 2 3 4 5 6 7 8 "Varicose veins". nhs.uk. 2017-10-23. Retrieved 2020-12-29.
  13. ↑ Chandra A. "Clinical review of varicose veins: epidemiology, diagnosis and management". GPonline.
  14. ↑ "Chronic Venous Insufficiency". The Lecturio Medical Concept Library. Retrieved 9 July 2021.
  15. ↑ "Varicose Vein Surgery Workup: Approach Considerations, Tests for Ruling Out Deep Venous Thrombosis As Cause, Tests for Demonstrating Reflux". emedicine.medscape.com. Retrieved 2022-04-12.
  16. 1 2 Goldman M. (1995) Sclerotherapy, Treatment of Varicose and Telangiectatic Leg Veins. Hardcover Text, 2nd Ed.
  17. ↑ Ng MY, Andrew T, Spector TD, Jeffery S (March 2005). "Linkage to the FOXC2 region of chromosome 16 for varicose veins in otherwise healthy, unselected sibling pairs". Journal of Medical Genetics. 42 (3): 235–239. doi:10.1136/jmg.2004.024075. PMC 1736007. PMID 15744037.
  18. ↑ Griesmann K (March 16, 2011). "Myth or Fact: Crossing Your Legs Causes Varicose Veins". Duke University Health System. Archived from the original on 2014-03-05. Retrieved March 1, 2014.
  19. ↑ Franceschi C (1996). "Physiopathologie Hémodynamique de l'Insuffisance veineuse". Chirurgie des veines des Membres Inférieurs. AERCV editions 23. Paris. p. 49.{{cite book}}: CS1 maint: location missing publisher (link)
  20. ↑ Hobbs, J. T. (14 September 2005). "Varicose veins arising from the pelvis due to ovarian vein incompetence". International Journal of Clinical Practice. 59 (10): 1195–1203. doi:10.1111/j.1368-5031.2005.00631.x. PMID 16178988.
  21. ↑ Giannoukas AD, Dacie JE, Lumley JS (July 2000). "Recurrent varicose veins of both lower limbs due to bilateral ovarian vein incompetence". Annals of Vascular Surgery. 14 (4): 397–400. doi:10.1007/s100169910075. PMID 10943794.
  22. ↑ Marsh P, Holdstock J, Harrison C, Smith C, Price BA, Whiteley MS (June 2009). "Pelvic vein reflux in female patients with varicose veins: comparison of incidence between a specialist private vein clinic and the vascular department of a National Health Service District General Hospital". Phlebology. 24 (3): 108–113. doi:10.1258/phleb.2008.008041. PMID 19470861.
  23. ↑ Ostler AE, Holdstock JM, Harrison CC, Fernandez-Hart TJ, Whiteley MS (October 2014). "Primary avalvular varicose anomalies are a naturally occurring phenomenon that might be misdiagnosed as neovascular tissue in recurrent varicose veins". Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2 (4): 390–396. doi:10.1016/j.jvsv.2014.05.003. PMID 26993544.
  24. ↑ Whiteley MS (September 2014). "Part one: for the motion. Venous perforator surgery is proven and does reduce recurrences". European Journal of Vascular and Endovascular Surgery. 48 (3): 239–242. doi:10.1016/j.ejvs.2014.06.044. PMID 25132056.
  25. ↑ Rutherford EE, Kianifard B, Cook SJ, Holdstock JM, Whiteley MS (May 2001). "Incompetent perforating veins are associated with recurrent varicose veins". European Journal of Vascular and Endovascular Surgery. 21 (5): 458–460. doi:10.1053/ejvs.2001.1347. PMID 11352523.
  26. ↑ Ayala C, Spellberg B, eds. (2009). Pathophysiology for the Boards and Wards (4th ed.). Lippincott Williams & Wilkins. ISBN 978-0-7817-8743-7.
  27. ↑ Blomgren L, Johansson G, Emanuelsson L, Dahlberg-Åkerman A, Thermaenius P, Bergqvist D (August 2011). "Late follow-up of a randomized trial of routine duplex imaging before varicose vein surgery". The British Journal of Surgery. 98 (8): 1112–1116. doi:10.1002/bjs.7579. PMID 21618499.
  28. ↑ O'Flynn N, Vaughan M, Kelley K (June 2014). "Diagnosis and management of varicose veins in the legs: NICE guideline". The British Journal of General Practice. 64 (623): 314–315. doi:10.3399/bjgp14X680329. PMC 4032011. PMID 24868066.
  29. ↑ Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, et al. (December 2004). "Revision of the CEAP classification for chronic venous disorders: consensus statement". Journal of Vascular Surgery. 40 (6): 1248–1252. doi:10.1016/j.jvs.2004.09.027. PMID 15622385.
  30. 1 2 Williams NS, Bulstrode CJ, O'Connell PR, Bailey H, McNeill Love RJ, eds. (2013). Bailey & Love's Short Practice of Surgery (26th ed.). London: Hodder Arnold. ISBN 978-1-4441-2127-8.
  31. ↑ Kheirelseid EA, Crowe G, Sehgal R, Liakopoulos D, Bela H, Mulkern E, et al. (March 2018). "Systematic review and meta-analysis of randomized controlled trials evaluating long-term outcomes of endovenous management of lower extremity varicose veins". Journal of Vascular Surgery. Venous and Lymphatic Disorders. 6 (2): 256–270. doi:10.1016/j.jvsv.2017.10.012. PMID 29292115.
  32. ↑ Hamann SA, Timmer-de Mik L, Fritschy WM, Kuiters GR, Nijsten TE, van den Bos RR (July 2019). "Randomized clinical trial of endovenous laser ablation versus direct and indirect radiofrequency ablation for the treatment of great saphenous varicose veins". The British Journal of Surgery. 106 (8): 998–1004. doi:10.1002/bjs.11187. PMC 6618092. PMID 31095724.
  33. ↑ Whing J, Nandhra S, Nesbitt C, Stansby G (August 2021). "Interventions for great saphenous vein incompetence". The Cochrane Database of Systematic Reviews. 2021 (8) CD005624. doi:10.1002/14651858.CD005624.pub4. PMC 8407488. PMID 34378180.
  34. ↑ NICE (July 23, 2013). "Varicose veins in the legs: The diagnosis and management of varicose veins. 1.2 Referral to a vascular service". National Institute for Health and Care Excellence. Retrieved August 25, 2014.
  35. ↑ Campbell B (August 2006). "Varicose veins and their management". BMJ. 333 (7562): 287–292. doi:10.1136/bmj.333.7562.287. PMC 1526945. PMID 16888305.
  36. ↑ Curri SB, Annoni F, Pabisch S, et al. (1989). Davy A, Stemmer R (eds.). Changes of cutaneous microcirculation from elasto-compression in chronic venous insufficiency. Phlébologie 89 : actes du 10e Congrès mondial, Union internationale de phlébologie, Strasbourg, 25-29 septembre 1989. Libbey Eurotext. pp. 852–854. ISBN 978-0-86196-216-7. OCLC 22812590.
  37. ↑ Yamany A, Hamdy B (July 2016). "Effect of sequential pneumatic compression therapy on venous blood velocity, refilling time, pain and quality of life in women with varicose veins: a randomized control study". Journal of Physical Therapy Science. 28 (7): 1981–1987. doi:10.1589/jpts.28.1981. PMC 4968489. PMID 27512247.
  38. ↑ van Rij AM, Chai J, Hill GB, Christie RA (December 2004). "Incidence of deep vein thrombosis after varicose vein surgery". The British Journal of Surgery. 91 (12): 1582–1585. doi:10.1002/bjs.4701. PMID 15386324.
  39. ↑ Munasinghe A, Smith C, Kianifard B, Price BA, Holdstock JM, Whiteley MS (July 2007). "Strip-track revascularization after stripping of the great saphenous vein". The British Journal of Surgery. 94 (7): 840–843. doi:10.1002/bjs.5598. PMID 17410557.
  40. ↑ Hammarsten J, Pedersen P, Cederlund CG, Campanello M (August 1990). "Long saphenous vein saving surgery for varicose veins. A long-term follow-up". European Journal of Vascular Surgery. 4 (4): 361–364. doi:10.1016/S0950-821X(05)80867-9. PMID 2204548.
  41. 1 2 3 Bellmunt-Montoya S, Escribano JM, Pantoja Bustillos PE, Tello-Díaz C, Martinez-Zapata MJ (September 2021). "CHIVA method for the treatment of chronic venous insufficiency". The Cochrane Database of Systematic Reviews. 2021 (9) CD009648. doi:10.1002/14651858.CD009648.pub4. PMC 8481765. PMID 34590305.
  42. ↑ Schouten R, Mollen RM, Kuijpers HC (May 2006). "A comparison between cryosurgery and conventional stripping in varicose vein surgery: perioperative features and complications". Annals of Vascular Surgery. 20 (3): 306–311. doi:10.1007/s10016-006-9051-x. PMID 16779510.
  43. 1 2 3 4 de Ávila Oliveira R, Riera R, Vasconcelos V, Baptista-Silva JC (December 2021). "Injection sclerotherapy for varicose veins". The Cochrane Database of Systematic Reviews. 2021 (12) CD001732. doi:10.1002/14651858.CD001732.pub3. PMC 8660237. PMID 34883526.
  44. ↑ Pak, L. K. et al. "Veins & Lymphatics," in Lange's Current Surgical Diagnosis & Treatment, 11th ed., McGraw-Hill.[page needed]
  45. ↑ de Ávila Oliveira, Ricardo; Riera, Rachel; Vasconcelos, Vladimir; Baptista-Silva, Jose Cc (2021-12-10). "Injection sclerotherapy for varicose veins". The Cochrane Database of Systematic Reviews. 2021 (12) CD001732. doi:10.1002/14651858.CD001732.pub3. PMC 8660237. PMID 34883526.
  46. ↑ Thibault P (2007). "Sclerotherapy and Ultrasound-Guided Sclerotherapy". In Bergan JJ (ed.). The Vein Book. pp. 189–199. doi:10.1016/B978-012369515-4/50023-5. ISBN 978-0-12-369515-4.
  47. ↑ Padbury A, Benveniste GL (December 2004). "Foam echo sclerotherapy of the small saphenous vein". Australian and New Zealand Journal of Phlebology. 8 (1).
  48. ↑ Finkelmeier, William R. (2004) "Sclerotherapy", Ch. 12 in ACS Surgery: Principles & Practice, WebMD, ISBN 0-9748327-4-X.
  49. ↑ Scurr JR, Fisher RK, Wallace SB (2007). "Anaphylaxis Following Foam Sclerotherapy: A Life Threatening Complication of Non Invasive Treatment For Varicose Veins". EJVES Extra. 13 (6): 87–89. doi:10.1016/j.ejvsextra.2007.02.005.
  50. ↑ Forlee, Martin V.; Grouden, Maria; Moore, Dermot J.; Shanik, Gregor (January 2006). "Stroke after varicose vein foam injection sclerotherapy". Journal of Vascular Surgery. 43 (1): 162–164. doi:10.1016/j.jvs.2005.09.032. PMID 16414404. Retrieved 8 October 2024.
  51. 1 2 3 Maeseneer, Marianne G. De; Kakkos, Stavros K.; Aherne, Thomas; Baekgaard, Niels; Black, Stephen; Blomgren, Lena; Giannoukas, Athanasios; Gohel, Manjit; Graaf, Rick de; Hamel-Desnos, Claudine; Jawien, Arkadiusz; Jaworucka-Kaczorowska, Aleksandra; Lattimer, Christopher R.; Mosti, Giovanni; Noppeney, Thomas (2022-02-01). "Editor's Choice – European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs". European Journal of Vascular and Endovascular Surgery. 63 (2): 184–267. doi:10.1016/j.ejvs.2021.12.024. hdl:2434/994577. ISSN 1078-5884. PMID 35027279.
  52. 1 2 "Thermische Verfahren - Deutsche Gesellschaft für Phlebologie und Lymphologie DGPL – Venenheilkunde". www.phlebology.de. Retrieved 2026-05-04.
  53. ↑ MSAC Assessment Report 1113 – Endovenous laser therapy (PDF) (Report). Medical Services Advisory Committee. 2008. ISBN 1-74186-605-7.
  54. ↑ Wallace, T.; El-Sheikha, J.; Nandhra, S.; Leung, C.; Mohamed, A.; Harwood, A.; Smith, G.; Carradice, D.; Chetter, I. (December 2018). "Long-term outcomes of endovenous laser ablation and conventional surgery for great saphenous varicose veins". The British Journal of Surgery. 105 (13): 1759–1767. doi:10.1002/bjs.10961. ISSN 1365-2168. PMID 30132797.
  55. ↑ Sayarer, Ceren; Arayici, Mehmet Emin; Gencpinar, Tugra; Bayrak, Serdar (2026-02-28). "Effectiveness of endovenous ablation techniques and surgery for great saphenous vein incompetence: a comprehensive meta-analysis of randomized controlled trials". Scientific Reports. 16 (1): 11424. Bibcode:2026NatSR..1611424S. doi:10.1038/s41598-026-42413-2. ISSN 2045-2322. PMC 13057195. PMID 41764322.
  56. 1 2 3 Gloviczki, Peter; Lawrence, Peter F.; Wasan, Suman M.; Meissner, Mark H.; Almeida, Jose; Brown, Kellie R.; Bush, Ruth L.; Iorio, Michael Di; Fish, John; Fukaya, Eri; Gloviczki, Monika L.; Hingorani, Anil; Jayaraj, Arjun; Kolluri, Raghu; Murad, M. Hassan (2023-03-01). "The 2022 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part I. Duplex Scanning and Treatment of Superficial Truncal Reflux: Endorsed by the Society for Vascular Medicine and the International Union of Phlebology". Journal of Vascular Surgery: Venous and Lymphatic Disorders. 11 (2): 231–261.e6. doi:10.1016/j.jvsv.2022.09.004. ISSN 2213-333X. PMID 36326210.
  57. ↑ Böhler, Kornelia (March 2023). "[Minimally invasive catheters in varicose vein treatment : New gold standard?]". Dermatologie (Heidelberg, Germany). 74 (3): 163–170. doi:10.1007/s00105-023-05113-w. ISSN 2731-7013. PMC 9981706. PMID 36811641.
  58. ↑ Kayssi, Ahmed; Pope, Marc; Vucemilo, Ivica; Werneck, Christiane (April 2015). "Endovenous radiofrequency ablation for the treatment of varicose veins". Canadian Journal of Surgery. 58 (2): 85–86. doi:10.1503/cjs.014914. ISSN 1488-2310. PMC 4373988. PMID 25799244.
  59. ↑ Chokkalingam Mani, Bhalaghuru; Delgado, Gabriel A. (2026), "Varicose Vein Treatment: Radiofrequency Ablation Therapy", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 32310580, retrieved 2026-07-15
  60. ↑ Almeida, Jose I.; Raines, Jeffrey K. (2007). "Principles of Ambulatory Phlebectomy". The Vein Book. pp. 247–255. doi:10.1016/B978-012369515-4/50030-2. ISBN 978-0-12-369515-4.
  61. ↑ Yazdani N (2021). "Medical Adhesive Closure". Melbourne Varicose Veins. Archived from the original on 2023-01-28. Retrieved 2022-03-09.
  62. ↑ Yassine Z (2021). "Medical Super Glue". The Vein Institute.
  63. ↑ Chollet, Daniel (12 October 2022). "ULTRasOns. au diable les varices". le Régional L'écho. p. 28.
  64. ↑ Tamparo C (2011). Diseases of the Human Body (5th ed.). Philadelphia, PA: F.A. Davis Company. p. 335. ISBN 978-0-8036-2505-1.
  65. ↑ "Varicose Veins – How to Prevent Them in Time?" (in Slovenian). Retrieved 11 March 2017.